Tagged Content
Tags > Medication Updates
Year: Medication:  Abilify (aripiprazole) Antipsychotics Belsomra Cymbalta Daytrana Effexor Farxiga Geodon Hysingla ER Lunesta Methylphenidate Naloxone/Evzio Naltrexone Olanzapine/Zyprexa Opioids Tanzeum Targiniq ER Tramadol Treatment for Alcohol Use Disorder Vynase Ziprasidone Zolpidem Zyprexa General Resources:   DEA Pharmacists' Manual FDA Medication Updates NIMH Mental Health Medications Guide         2015 FDA reports permanent skin-color changes with use of Daytrana patch (methylphenidate transdermal system) The FDA is warning that use of the Daytrana patch (methylphenidate transdermal system) for ADHD may lead to permanent loss of skin color. First Generic Abilify (aripiprazole) approved by FDA Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder. New Guidance on Medication-Assisted Treatment for Alcohol Use Disorder SAMHSA guide for expanding use of medication in clinical practice for the treatment of alcohol use disorder.



View all tags
View RSS XML